RIPK2 (also known as RIP2) is also involved in B cell lymphoma cell survival and mediates the activation of NF-κB and MAPK pathways, associated with the TNF receptor family [67]. Here, NFKB1 is linked to B-cell non-Hodgkin lymphoma.